HR job title
- Professor
- Contact Info
- 1 254 724 8878
- ORCiD
- 0000-0002-3921-9056
Hicks, Paul Professor
Positions
- Associate Dean, College of Medicine
- Professor, Psychiatry, College of Medicine
- Overview
- Publications
- Research
- Background
- Contact
- Other
- View All
Overview
Publications
selected publications
-
academic article
-
Zisook, S., Johnson, G. R., Hicks, P., Chen, P., Beresford, T., Michalets, J. P., ... Mohamed, S.
(2020).
Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment‐resistant major depressive disorder: A VAST‐D report. DEPRESSION AND ANXIETY.
38(2), 185-195.
-
Mohamed, S., Johnson, G. R., Sevilimedu, V., Rao, S. D., Hicks, P. B., Chen, P., ... Zisook, S.
(2020).
Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial. The Journal of Clinical Psychiatry.
81(4),
-
Hicks, P. B., Sevilimedu, V., Johnson, G. R., Tal, I., Chen, P., Davis, L. L., ... Zisook, S.
(2019).
Predictability of Nonremitting Depression After First 2 Weeks of Antidepressant Treatment: A VAST‐D Trial Report. Psychiatric Research and Clinical Practice.
1(2), 58-67.
-
Zisook, S., Johnson, G. R., Tal, I., Hicks, P., Chen, P., Davis, L., ... Mohamed, S.
(2019).
General Predictors and Moderators of Depression Remission: A VAST-D Report. AMERICAN JOURNAL OF PSYCHIATRY.
176(5), 348-357.
-
Mohamed, S., Johnson, G. R., Chen, P., Hicks, P. B., Davis, L. L., Yoon, J., ... Little, J. T.
(2017).
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. JAMA.
318(2), 132-145.
-
Zisook, S., Tal, I., Weingart, K., Hicks, P., Davis, L. L., Chen, P., ... Mohamed, S.
(2016).
Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require “next-step” treatments: A VAST-D report. JOURNAL OF AFFECTIVE DISORDERS.
206, 232-240.
-
Krystal, J. H., Pietrzak, R. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J., Jones, K. M., ... Krystal, A. D.
(2016).
Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504. The Journal of Clinical Psychiatry.
77(4), 483-491.
-
Mohamed, S., Johnson, G. R., Vertrees, J. E., Guarino, P. D., Weingart, K., Young, I. T., ... Zisook, S.
(2015).
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations. Psychiatry Research.
229(3), 760-770.
-
Leatherman, S. M., Liang, M. H., Krystal, J. H., Lew, R. A., Valley, D., Thwin, S. S., & Rosenheck, R. A.
(2014).
Differences in Treatment Effect Among Clinical Subgroups in a Randomized Clinical Trial of Long-Acting Injectable Risperidone and Oral Antipsychotics in Unstable Chronic Schizophrenia. JOURNAL OF NERVOUS AND MENTAL DISEASE.
202(1), 13-17.
-
Copeland, L. A., Pugh, M. J., Hicks, P. B., & Noel, P. H.
(2012).
Use of Obesity-Related Care by Psychiatric Patients. Psychiatric Services.
63(3), 230-236.
-
Young, K. A., Bonkale, W. L., Holcomb, L. A., Hicks, P. B., & German, D. C.
(2008).
Major depression, 5HTTLPR genotype, suicide and antidepressant influences on thalamic volume. British Journal of Psychiatry.
192(4), 285-289.
-
Young, K. A., Holcomb, L. A., Bonkale, W. L., Hicks, P. B., Yazdani, U., & German, D. C.
(2007).
5HTTLPR Polymorphism and Enlargement of the Pulvinar: Unlocking the Backdoor to the Limbic System. BIOLOGICAL PSYCHIATRY.
61(6), 813-818.
-
Schubert, M. H., Young, K. A., & Hicks, P. B.
(2006).
Galantamine Improves Cognition in Schizophrenic Patients Stabilized on Risperidone. BIOLOGICAL PSYCHIATRY.
60(6), 530-533.
-
Browning, J. L., Patel, T., Brandt, P. C., Young, K. A., Holcomb, L. A., & Hicks, P. B.
(2005).
Clozapine and the mitogen-activated protein kinase signal transduction pathway: Implications for antipsychotic actions. BIOLOGICAL PSYCHIATRY.
57(6), 617-623.
-
Young, K. A., Holcomb, L. A., Yazdani, U., Hicks, P. B., & German, D. C.
(2004).
Elevated Neuron Number in the Limbic Thalamus in Major Depression. AMERICAN JOURNAL OF PSYCHIATRY.
161(7), 1270-1277.
-
Wadenberg, M., Browning, J. L., Young, K. A., & Hicks, P. B.
(2001).
Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats. Pharmacology Biochemistry and Behavior.
68(3), 363-370.
-
Young, K. A., Smith, M., Rawls, T., Elliott, D. B., Russell, I. S., & Hicks, P. B.
(2001).
N100 evoked potential latency variation and startle in schizophrenia. NEUROREPORT.
12(4), 767-773.
-
Young, K. A., Manaye, K. F., Liang, C., Hicks, P. B., & German, D. C.
(2000).
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. BIOLOGICAL PSYCHIATRY.
47(11), 944-953.
-
Barwick, V. S., Jones, D. H., Richter, J. T., Hicks, P. B., & Young, K. A.
(2000).
Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats. NEUROREPORT.
11(2), 267-270.
-
Wadenberg, M., & Hicks, P. B.
(1999).
The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?. Neuroscience & Biobehavioral Reviews.
23(6), 851-862.
-
Wadenberg, M., Young, K. A., Richter, J. T., & Hicks, P. B.
(1999).
Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat. Neuropharmacology.
38(1), 151-156.
-
Wadenberg, M., Hicks, P. B., Richter, J. T., & Young, K. A.
(1998).
Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907. BIOLOGICAL PSYCHIATRY.
44(6), 508-515.
-
Wadenberg, M., Young, K. A., Trompler, R. A., Zavodny, R. A., Richter, T. J., & Hicks, P. B.
(1997).
A novel computer-controlled conditioned avoidance apparatus for rats. Journal of Pharmacological and Toxicological Methods.
38(4), 211-215.
-
Jeste, D. V., Klausner, M., Brecher, M., Clyde, C., Jones, R., & ARCS Study Group, ..
(1997).
A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. Psychopharmacology.
131(3), 239-247.
-
Young, K. A., Hicks, P. B., Randall, P. K., & Wilcox, R. E.
(1994).
Behavioral and frontal cortical metabolic effects of apomorphine and muscimol microinjections into the mediodorsal thalamic nucleus. J NEURAL TRANSM GEN SECT.
98(2), 119-132.
-
Hicks, P., Young, K., & Zavodny, R.
(1993).
Further evidence for a 5-HT-1C modulation of apomorphine-induced locomotor activity. SCHIZOPHRENIA RESEARCH.
9(2-3), 238-238.
-
Young, K. A., Zavodny, R., & Hicks, P. B.
(1993).
Effects of serotonergic agents on apomorphine-induced locomotor activity. Psychopharmacology.
110(1-2), 97-102.
-
Young, K. A., Zavodny, R., & Hicks, P. B.
(1991).
Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment. J NEURAL TRANSM GEN SECT.
86(3), 223-228.
-
Hicks, P. B.
(1990).
The effect of serotonergic agents on haloperidol-induced catalepsy. LIFE SCIENCES.
47(18), 1609-1615.
-
HICKS, P. B., VINOGRADOV, S., RINEY, S. J., SU, K., & CSERNANSKY, J. G.
(1989).
A Preliminary Dose-Ranging Trial of Proglumide for the Treatment of Refractory Schizophrenics. Journal of Clinical Psychopharmacology.
9(3), 209-212.
-
Hicks, P., Rolsten, C., Brizzee, D., & Samorajski, T.
(1983).
Age-related changes in rat brain capillaries. NEUROBIOLOGY OF AGING.
4(1), 69-75.
-
Misra, C. H., Hicks, P., Rolsten, C., Smith, R. C., & Schoolar, J. C.
(1982).
Regional uptake of [35S]-cysteine in rat brain after arterial injection. Research Communications in Molecular Pathology and Pharmacology.
37(1), 155-158.
-
Rolsten, C., Hicks, P., Samorajski, T., & Schoolar, J.
(1982).
Decreased response latency time of aged C57BL/6J male mice to benzodiazepines. 5(4), 146-147.
-
Hicks, P., Rolsten, C., Taylor, D., & Samorajski, T.
(1982).
Plasma Choline and Blood Cholinesterases in Aged Rats. Gerontology.
28(2), 104-107.
-
Hicks, P., Strong, R., Schoolar, J. C., & Samorajski, T.
(1980).
Aging alters amphetamine-induced stereotyped gnawing and neostriatal elimination of amphetamine in mice. LIFE SCIENCES.
27(9), 715-722.
-
Strong, R., Hicks, P., Hsu, L., Bartus, R. T., & Enna, S. J.
(1980).
Age-related alterations in the rodent brain cholinergic system and behavior. NEUROBIOLOGY OF AGING.
1(1), 59-63.
-
Smith, R. C., Strong, J. R., Hicks, P. B., & Samorajski, T.
(1979).
Behavioral evidence for supersensitivity after chronic bromocriptine administration. Psychopharmacology.
60(3), 241-246.
-
Strong, R., Smith, R., & Hicks, P.
(1978).
Increased behavioral effects of dopamine agonists in aged rodents. PHARMACOLOGIST.
20(3),
-
Zisook, S., Johnson, G. R., Hicks, P., Chen, P., Beresford, T., Michalets, J. P., ... Mohamed, S.
(2020).
Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment‐resistant major depressive disorder: A VAST‐D report. DEPRESSION AND ANXIETY.
38(2), 185-195.
-
conference paper
-
Young, K. A., Bonkale, W., Sachsenmaier, S., & Hicks, P.
(2009).
VA/VL THALAMIC CELL NUMBER IN SCHIZOPHRENIA AND MOOD DISORDERS. SCHIZOPHRENIA BULLETIN.
226-227.
-
Young, K. A., Holcomb, L. A., Bonkale, W. L., & Hicks, P. B.
(2007).
Normal oligodendrocyte cell numbers in anterior thalamus in schizophrenia Normal oligodendrocyte cell numbers in anterior thalamus in schizophrenia. SCHIZOPHRENIA BULLETIN.
274-274.
-
Browning, J. L., Young, K. A., & Hicks, P. B.
(2005).
The MEK/ERK map kinase pathway in antipsychotic actions. SCHIZOPHRENIA BULLETIN.
296-296.
-
Schubert, M. H., Young, K. A., Justice, S. B., Durgam, S. K., Schmitz, W. M., House, M. D., & Hicks, P. B.
(2005).
Cognitive improvement in schizophrenia and schizoaffective disorder by augmentation of risperidone with galantamine. SCHIZOPHRENIA BULLETIN.
503-503.
-
German, D., Yazdani, U., Hicks, P., & Young, K.
(2004).
Increased number of neurons in the limbic thalamus in major depressive disorder. BIOLOGICAL PSYCHIATRY.
84S-84S.
-
Young, K. A., Skol, A. S., Tsuang, D. W., Faraone, S. V., Bingham, S., Prabhudesai, S., ... Tsuang, M. T.
(2003).
Association of NOTCH4 with schizophrenia in VA coop study #366. SCHIZOPHRENIA RESEARCH.
92-92.
-
Browning, J. L., Young, K. A., Holcomb, L. A., Jones, D. H., & Hicks, P. B.
(2003).
The role of the map kinase ERK pathway in the antipsychotic actions of clozapine. SCHIZOPHRENIA RESEARCH.
309-309.
-
Hicks, P. B., Browning, J. L., Schubert, M. H., & Young, K. A.
(2003).
5-HT2A antagonism does not affect catalepsy in rats. SCHIZOPHRENIA RESEARCH.
356-357.
-
Holcomb, L. A., Hicks, P. B., Metz, D. S., Stepp, S., & Young, K. A.
(2001).
Anterior thalamic volume in schizophrenia and mood disorders. SCHIZOPHRENIA RESEARCH.
61-61.
-
Young, K. A., Russell, I. S., & Hicks, P. B.
(2001).
Changes in evoked potential latency variation over time are associated with changes in EP and startle gating in schizophrenic patients. SCHIZOPHRENIA RESEARCH.
126-126.
-
Browning, J. L., Patel, T., Brandt, P. C., Young, K. A., & Hicks, P. B.
(2001).
Is the mechanism of action of antipsychotic agents mediated through the MAP kinase signal transduction system?. SCHIZOPHRENIA RESEARCH.
87-88.
-
Holcomb, L. A., Manaye, E. F., German, D. C., Hicks, P. B., & Young, K. A.
(1999).
GFAP and Rab3a immunoreactivity in the thalamus of schizophrenics. SCHIZOPHRENIA RESEARCH.
81-81.
-
Young, K. A., Smith, M., Clark, W., Hicks, P. B., & Russell, I. S.
(1999).
Incidence of startle prepulse inhibition deficits in schizophrenics. SCHIZOPHRENIA RESEARCH.
188-188.
-
Hicks, P. B., Browning, J., Barwick, S., Jones, D., Wadenberg, M. L., Richter, J. T., & Young, K. A.
(1999).
M100,907 acts at both the nucleus accumbens and the prefrontal cortex to mediate the enhancement of the suppression of conditioned avoidance response by haloperidol. SCHIZOPHRENIA RESEARCH.
115-115.
-
Barwick, V. S., Manaye, K. F., Brandt, A., German, D. C., Hicks, P. B., & Young, K. A.
(1999).
Stereological estimate of total thalamic neuron number in schizophrenics. SCHIZOPHRENIA RESEARCH.
79-79.
-
Wadenberg, M., Hicks, P. B., Young, K. A., & Richter, J. T.
(1997).
216 Further evidence for a role of the 5-HT2A receptor in the mediation of antipsychotic activity. SCHIZOPHRENIA RESEARCH.
83-83.
-
Young, K. A., Brady, M. D., & Hicks, P. B.
(1995).
Psychophysiological evidence for neuroleptic-induced depolarization block in schizophrenics. SCHIZOPHRENIA RESEARCH.
170-171.
-
Young, K. A., Bonkale, W., Sachsenmaier, S., & Hicks, P.
(2009).
VA/VL THALAMIC CELL NUMBER IN SCHIZOPHRENIA AND MOOD DISORDERS. SCHIZOPHRENIA BULLETIN.
226-227.
Research
principal investigator on
- IPA for Jeffrey Browning awarded by Central Texas Veterans Health Care System - (Waco, Texas, United States) 2017 - 2018
Background
education and training
- M.D. in Medicine, Baylor College of Medicine - (Houston, Texas, United States) 1983
- Ph.D. in Pharmacology, Baylor College of Medicine - (Houston, Texas, United States) 1983
- Stanford Medicine - (Stanford, California, United States) , Medical Residency 1987
- Baylor College of Medicine - (Houston, Texas, United States) , Medical Residency 1984
Contact
first name
- Paul
has last name
- Hicks
mailing address
-
Texas A&M Health Science Center
Instructional Admin
1114 TAMUS
Temple, TX 76508
USA
Other
- phicks@tamu.edu